Literature DB >> 18486430

Renin and aldosterone but not the natriuretic peptide correlate with obsessive craving in medium-term abstinent alcohol-dependent patients: a longitudinal study.

Lorenzo Leggio1, Anna Ferrulli, Silvia Cardone, Antonio Miceli, George A Kenna, Giovanni Gasbarrini, Robert M Swift, Giovanni Addolorato.   

Abstract

Both animal and human studies suggest that volume-regulating hormones could play a role in alcohol dependence as well as in alcohol craving. The role of the volume-regulating hormones, renin, aldosterone, and the N-terminal pro B-type natriuretic peptide (NT-proBNP) in alcohol craving was therefore evaluated in the present study. Twenty-five actively drinking alcohol-dependent patients satisfied the inclusion criteria and were enrolled into the study. The volume-regulating hormones, renin, aldosterone, and the NT-proBNP, and craving measurements--Obsessive-Compulsive Drinking Scale (OCDS) and Penn Alcohol Craving Scale (PACS)--were performed at baseline and after 12 weeks. Sixteen patients remained totally abstinent for the entire 12 weeks and were available for the second assessments. At baseline, no correlations between hormones and craving scores were found with either the 25 patients initially enrolled or the 16 abstinent patients. At 12 weeks, a significant increase of renin and a significant decrease of aldosterone were observed. Aldosterone showed a significant direct correlation with the obsessive OCDS subscore (r=0.59, P=.016) and a trend toward a significant direct correlation with the PACS score (r=0.48, P=.057). Renin demonstrated a significant direct correlation with the obsessive OCDS subscore (r=0.51, P=.041) and with the PACS score (r=0.56, P=.025). The NT-proBNP never correlated with craving measurements. In conclusion, the renin-aldosterone axis could play a role in craving in medium-term abstinent patients and thereby leading to the hypothesis that alcohol craving could be influenced by the fluid volume intake.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18486430     DOI: 10.1016/j.alcohol.2008.03.128

Source DB:  PubMed          Journal:  Alcohol        ISSN: 0741-8329            Impact factor:   2.405


  16 in total

1.  Baclofen promotes alcohol abstinence in alcohol dependent cirrhotic patients with hepatitis C virus (HCV) infection.

Authors:  L Leggio; A Ferrulli; A Zambon; F Caputo; G A Kenna; R M Swift; G Addolorato
Journal:  Addict Behav       Date:  2011-12-27       Impact factor: 3.913

Review 2.  Novel therapeutic strategies for alcohol and drug addiction: focus on GABA, ion channels and transcranial magnetic stimulation.

Authors:  Giovanni Addolorato; Lorenzo Leggio; F Woodward Hopf; Marco Diana; Antonello Bonci
Journal:  Neuropsychopharmacology       Date:  2011-10-26       Impact factor: 7.853

3.  The mineralocorticoid receptor antagonist spironolactone reduces alcohol self-administration in female and male rats.

Authors:  Viren H Makhijani; Kalynn Van Voorhies; Joyce Besheer
Journal:  Pharmacol Biochem Behav       Date:  2018-08-29       Impact factor: 3.533

4.  Higher pretreatment blood pressure is associated with greater alcohol drinking reduction in alcohol-dependent individuals treated with doxazosin.

Authors:  Carolina L Haass-Koffler; Kimberly Goodyear; William H Zywiak; Molly Magill; Sarah E Eltinge; Paul M Wallace; Victoria M Long; Nitya Jayaram-Lindström; Robert M Swift; George A Kenna; Lorenzo Leggio
Journal:  Drug Alcohol Depend       Date:  2017-05-16       Impact factor: 4.492

5.  Intravenous administration of ghrelin increases serum cortisol and aldosterone concentrations in heavy-drinking alcohol-dependent individuals: Results from a double-blind, placebo-controlled human laboratory study.

Authors:  Carolina L Haass-Koffler; Victoria M Long; Mehdi Farokhnia; Molly Magill; George A Kenna; Robert M Swift; Lorenzo Leggio
Journal:  Neuropharmacology       Date:  2019-07-13       Impact factor: 5.250

6.  Effects of naltrexone on cortisol levels in heavy drinkers.

Authors:  Lara A Ray; James Mackillop; Lorenzo Leggio; Marilee Morgan; Kent E Hutchison
Journal:  Pharmacol Biochem Behav       Date:  2008-09-13       Impact factor: 3.533

7.  Acute interaction of baclofen in combination with alcohol in heavy social drinkers.

Authors:  Suzette M Evans; Adam Bisaga
Journal:  Alcohol Clin Exp Res       Date:  2008-10-06       Impact factor: 3.455

8.  Mifepristone Decreases Chronic Voluntary Ethanol Consumption in Rhesus Macaques.

Authors:  Vanessa A Jimenez; Nicole A R Walter; Tatiana A Shnitko; Natali Newman; Kaya Diem; Lauren Vanderhooft; Hazel Hunt; Kathleen A Grant
Journal:  J Pharmacol Exp Ther       Date:  2020-09-01       Impact factor: 4.030

9.  A human laboratory pilot study with baclofen in alcoholic individuals.

Authors:  Lorenzo Leggio; William H Zywiak; John E McGeary; Steven Edwards; Samuel R Fricchione; Jessica R Shoaff; Giovanni Addolorato; Robert M Swift; George A Kenna
Journal:  Pharmacol Biochem Behav       Date:  2012-12-19       Impact factor: 3.533

10.  Sleep disturbance as a universal risk factor for relapse in addictions to psychoactive substances.

Authors:  Kirk J Brower; Brian E Perron
Journal:  Med Hypotheses       Date:  2009-11-11       Impact factor: 1.538

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.